Andrew Feinberg appears in Brel Digital’s verified company_founders attribution for BostonGene based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.
Company context (from the verified BostonGene profile): Waltham biotechnology company applying an AI foundation model of tumor and immune biology to precision oncology and drug development
Why the company matters (verified company field): BostonGene represents biopharma's shift toward biologically grounded AI foundation models for trial design and patient selection — its 2026 Frost & Sullivan recognition and CEO Andrew Feinberg's cross-industry AI governance visibility reflect oncology AI maturing into enterprise decision infrastructure.
Official company website on file: https://www.bostongene.com. Readers should consult that site and the Sources section for primary evidence.
Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.